Polar Capital Holdings PLC Xenon Pharmaceuticals Inc. Transaction History

Polar Capital Holdings PLC

  • $17.4 Billion
  • Q2 2025

A detailed history of Polar Capital Holdings PLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 2,703,256 shares of XENE stock, worth $104 Million. This represents 0.49% of its overall portfolio holdings.

Number of Shares
2,703,256
Previous 2,623,039 3.06%
Holding current value
$104 Million
Previous $88 Million 3.85%
% of portfolio
0.49%
Previous 0.59%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$28.23 - $38.37 $2.26 Million - $3.08 Million
80,217 Added 3.06%
2,703,256 $84.6 Million
Q1 2025

May 15, 2025
SELL
$33.55 - $40.74 $2.5 Million - $3.04 Million
-74,618 Reduced 2.77%
2,623,039 $88 Million
Q4 2024

Feb 14, 2025
BUY
$38.14 - $45.74 $9.65 Million - $11.6 Million
253,012 Added 10.35%
2,697,657 $106 Million
Q3 2024

Nov 14, 2024
SELL
$36.12 - $43.96 $3.3 Million - $4.02 Million
-91,413 Reduced 3.6%
2,444,645 $96.2 Million
Q2 2024

Aug 14, 2024
SELL
$36.25 - $43.75 $2.76 Million - $3.33 Million
-76,050 Reduced 2.91%
2,536,058 $98.9 Million
Q1 2024

May 15, 2024
SELL
$42.66 - $50.04 $19.4 Million - $22.7 Million
-454,520 Reduced 14.82%
2,612,108 $112 Million
Q4 2023

Feb 14, 2024
BUY
$28.7 - $46.46 $1.8 Million - $2.92 Million
62,881 Added 2.09%
3,066,628 $141 Million
Q3 2023

Nov 14, 2023
SELL
$34.16 - $39.73 $625,947 - $728,012
-18,324 Reduced 0.61%
3,003,747 $103 Million
Q2 2023

Dec 13, 2023
BUY
$34.84 - $43.54 $183,014 - $228,715
5,253 Added 0.17%
3,022,071 $116 Million
Q2 2023

Aug 14, 2023
BUY
$34.84 - $43.54 $105 Million - $132 Million
3,022,071 New
3,022,071 $116 Million
Q1 2023

Dec 13, 2023
BUY
$33.46 - $40.35 $437,355 - $527,414
13,071 Added 0.44%
3,016,818 $108 Million
Q4 2022

Feb 14, 2023
BUY
$33.06 - $39.43 $12.7 Million - $15.1 Million
383,152 Added 14.39%
3,045,874 $120 Million
Q3 2022

Nov 14, 2022
BUY
$30.79 - $39.82 $3.78 Million - $4.88 Million
122,663 Added 4.83%
2,662,722 $96.1 Million
Q2 2022

Aug 15, 2022
BUY
$25.44 - $35.16 $8.9 Million - $12.3 Million
350,000 Added 15.98%
2,540,059 $77.3 Million
Q1 2022

May 16, 2022
BUY
$25.09 - $33.13 $12.6 Million - $16.6 Million
502,015 Added 29.74%
2,190,059 $67 Million
Q4 2021

Feb 14, 2022
BUY
$15.6 - $35.4 $26.3 Million - $59.8 Million
1,688,044 New
1,688,044 $52.7 Million

Others Institutions Holding XENE

# of Institutions
221
Shares Held
73.2M
Call Options Held
336K
Put Options Held
309K
View Full List

About Xenon Pharmaceuticals Inc.

XENE Quotes by TradingView
  • Ticker XENE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,263,500
  • Market Cap $2.41B
  • Description
  • Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...
More about XENE
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email